- Filed
- Feb 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Feb 13, 2026 | 7.01M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 6.89M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 6.84M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2024 | 7.28M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2024 | 5.39M sh |
| Operating Cash Flow | Q2 2026 · Dec 31, 2025 | −$92.59K |
| Operating Cash Flow | Q2 2026 · Dec 31, 2024 | −$4.48M |
| Long Term Debt | Q2 2026 · Dec 31, 2025 | $61.38K |
| Long Term Debt | Q2 2026 · Jun 30, 2025 | $73.42K |
| Cash And Equivalents | Q2 2026 · Dec 31, 2025 | $1.77M |
| Cash And Equivalents | Q2 2026 · Jun 30, 2025 | $1.88M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | −$11.82M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | −$7.94M |
| Stockholders Equity | Q2 2026 · Jun 30, 2025 | −$5.36M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $2.2M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $457.24K |
| Stockholders Equity | Q2 2026 · Jun 30, 2024 | −$4M |
| Current Liabilities | Q2 2026 · Dec 31, 2025 | $33.95M |
| Current Liabilities | Q2 2026 · Jun 30, 2025 | $30.4M |
| Total Liabilities | Q2 2026 · Dec 31, 2025 | $53.87M |
| Total Liabilities | Q2 2026 · Jun 30, 2025 | $31.36M |
| Current Assets | Q2 2026 · Dec 31, 2025 | $19.84M |
| Current Assets | Q2 2026 · Jun 30, 2025 | $23.65M |
| Total Assets | Q2 2026 · Dec 31, 2025 | $42.04M |
| Total Assets | Q2 2026 · Jun 30, 2025 | $26M |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | −$0.62 |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | −$1.05 |
| Eps Diluted | Q2 2026 · Dec 31, 2024 | $0.20 |
| Eps Diluted | Q2 2026 · Dec 31, 2024 | −$0.16 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | −$0.62 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | −$1.05 |
| Eps Basic | Q2 2026 · Dec 31, 2024 | $0.20 |
| Eps Basic | Q2 2026 · Dec 31, 2024 | −$0.16 |
| Sga Expense | Q2 2026 · Dec 31, 2025 | $3.1M |
| Sga Expense | Q2 2026 · Dec 31, 2025 | $5.53M |
| Sga Expense restated | Q2 2026 · Dec 31, 2024 | $2.04M |
| Sga Expense restated | Q2 2026 · Dec 31, 2024 | $3M |
| Rd Expense | Q2 2026 · Dec 31, 2025 | $193.21K |
| Rd Expense | Q2 2026 · Dec 31, 2025 | $499.64K |
| Rd Expense restated | Q2 2026 · Dec 31, 2024 | $717.27K |
| Rd Expense restated | Q2 2026 · Dec 31, 2024 | $724.3K |
| Net Income | Q2 2026 · Dec 31, 2025 | −$4.29M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$7.15M |
| Net Income | Q2 2026 · Sep 30, 2025 | −$2.87M |
| Net Income | Q2 2026 · Dec 31, 2024 | $1.42M |
| Net Income | Q2 2026 · Dec 31, 2024 | −$842.64K |
| Net Income | Q2 2026 · Sep 30, 2024 | −$2.27M |
| Operating Income | Q2 2026 · Dec 31, 2025 | −$2.22M |
| Operating Income | Q2 2026 · Dec 31, 2025 | −$3.11M |
| Operating Income | Q2 2026 · Dec 31, 2024 | −$2.24M |
| Operating Income | Q2 2026 · Dec 31, 2024 | −$4.05M |
| Gross Profit | Q2 2026 · Dec 31, 2025 | $2.22M |
| Gross Profit | Q2 2026 · Dec 31, 2025 | $4.96M |
| Gross Profit | Q2 2026 · Dec 31, 2024 | $2.19M |
| Gross Profit | Q2 2026 · Dec 31, 2024 | $2.59M |
| Revenue | Q2 2026 · Dec 31, 2025 | $16.72M |
| Revenue | Q2 2026 · Dec 31, 2025 | $36.94M |
| Revenue | Q2 2026 · Dec 31, 2024 | $17.48M |
| Revenue | Q2 2026 · Dec 31, 2024 | $40.59M |
| Capex | Q2 2026 · Dec 31, 2024 | $68.34K |